Concepedia

Jeyanthi Ramanarayanan

JR

5

Publications

122

Citations

5

H-Index

2004

Active since

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Jeyanthi Ramanarayanan is an author at Roswell Park Comprehensive Cancer Center specializing in oncology, cancer research, and immunotherapy.

Top concepts

MedicineOncologyImmunotherapyCancer ResearchHealthPathologyCell DeathHematologyImmunologyAutoimmunity

Publications per year

2004–2009

5

Publications

5

Pro‐apoptotic therapy with the oligonucleotide Genasense<sup>TM</sup> (oblimersen sodium) targeting Bcl‐2 protein expression enhances the biological anti‐tumour activity of rituximab

Jeyanthi Ramanarayanan, Francisco J. Hernandez‐Ilizaliturri, Asher Chanan‐Khan et al. · British Journal of Haematology · 2004 · 43 citations · Full text

Immunology, Cell Death, Pathology +20

Acute drug induced hepatitis due to erlotinib.

Jeyanthi Ramanarayanan, Sarah L Scarpace · PubMed · 2007 · 28 citations

Chronic myeloid leukemia after treatment of lymphoid malignancies: Response to imatinib mesylate and favorable outcomes in three patients

Jeyanthi Ramanarayanan, Lauren M. Dunford, Maria R. Baer et al. · Leukemia Research · 2005 · 23 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Myeloid Leukemia +12

BCNU toxicity presenting with a large pericardial and pleural effusion.

Ganapathy Subramaniam Krishnan, Vijay Chaudhary, Anas Al-Janadi et al. · PubMed · 2008 · 17 citations

Targeted treatment of chronic myeloid leukemia: role of imatinib

Jeyanthi Ramanarayanan · OncoTargets and Therapy · 2009 · 11 citations · Full text

Rows per page

1–5 of 5